|
⚲
|
| Keyboard |
| Advent Life Sciences Llp | |
|---|---|
| Firm | |
| Address | 27 Fitzroy Square London, X0 W1T 6ES |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Advent Life Sciences Growth Fund LP | 021-527005 | Executive Officer | 9.8 M | ||
| Advent Life Sciences LLP | |||||
| Advent-Harrington Impact Fund LP | 021-380008 | Executive Officer | 41.6 M | 52.2 M | |
| Advent Life Sciences Fund III LP | 021-327448 | Executive Officer | 24.8 M | 154.1 M | |
| Advent Life Sciences Fund II LP | 021-224448 | Executive Officer | 226.3 M of 226.3 M |
159.2 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 1,231,178 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 404,937 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 43,822 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 14,412 | ||
|
Axonics Inc AXNX
Series B-2 Preferred Stock · derivative
|
2018-11-02 | Conversion | 1,025,981 | $0.00 | |
|
Axonics Inc AXNX
Series C Preferred Stock · derivative
|
2018-11-02 | Conversion | 337,447 | $0.00 | |
|
Axonics Inc AXNX
Series C Preferred Stock · derivative
|
2018-11-02 | Conversion | 12,010 | $0.00 | |
|
Axonics Inc AXNX
Series B-2 Preferred Stock · derivative
|
2018-11-02 | Conversion | 36,518 | $0.00 | |
|
Aravive Inc VSAR
Common Stock
|
2015-01-22 | Buy | 55,000 | $17.25 | 948,750 |
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 1,258,086 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 176,813 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 78,228 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 154,178 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 489,253 | ||
|
Aravive Inc VSAR
Warrants to Purchase Series B Preferred Stock · derivative
|
2014-03-26 | Option exercise | 506,376 | $0.00 | |
|
Aravive Inc VSAR
Series E Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 1,773,049 | $0.00 | |
|
Aravive Inc VSAR
Series B Convertible Preferred Stock · derivative
|
2014-03-26 | Option exercise | 506,376 | $0.00 | |
|
Aravive Inc VSAR
Series B Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 14,468,020 | $0.00 | |
|
Aravive Inc VSAR
Series C Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 5,626,413 | $0.00 | |
|
Aravive Inc VSAR
Series D-1 Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 2,033,350 | $0.00 | |
| showing 20 of 22 most recent transactions | |||||